Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
| Buyback Record Date | August 4, 2023 |
| Buyback Open Date | August 9, 2023 |
| Buyback Closing Date | August 17, 2023 |
| Issue Size (Shares) | 0.07 Crores |
| Issue Size (Amount) | ₹59.85 Crores |
| Buyback Price | ₹900 per Share |
Aarti Drugs Limited is coming up with BuyBack of the face value of ₹10 each, for an amount of ₹0.07 Crores ('Base Issue Size') with an option to retain oversubscription up to ₹59.85 Crores.
Aarti Drugs Limited is one of the leading pharma companies in India .The company manufactures over 40 products comprising of bulk actives, key intermediates, and specialty chemicals. Its product portfolio includes anti-biotic, anti-protozoal, anti-inflammatory, anti-fungal, anti-diabetic, cardio-protectant, vitamins, anti-arthritis, sedatives therapeutic groups that help in lifesaving and lifestyle related diseases .
The issue opens on Aug 9, 2023 and closes for subscription on Aug 17, 2023. The shares of the company to be list at BSE, NSE.
The public issue of Aarti Drugs Limited opens on Aug 9, 2023 and closes for subscription on Aug 17, 2023.
The Aarti Drugs Buyback 2023 are proposed to list at BSE, NSE.
This page provides Buyback news of Aarti Drugs Buyback 2023. The Aarti Drugs Buyback 2023 watch offers the latest Buyback issue news and keep you updated with the latest Buyback news in India.
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
